Literature DB >> 2827073

Adenosine and neuropeptide Y enhance alpha 1-adrenoceptor-induced accumulation of inositol phosphates and attenuate forskolin-induced accumulation of cyclic AMP in rat vas deferens.

J Häggblad1, B B Fredholm.   

Abstract

The action on alpha 1-adrenoceptor-coupled polyphosphoinositide breakdown of two modulators of adrenergic neurotransmission, adenosine and neuropeptide Y (NPY), was studied in pieces of rat vas deferens. Both adenosine and NPY dose-dependently increased the accumulation of inositol phosphates induced by phenylephrine (50 microM), but neither of the two compounds had any effect alone on inositol phosphate accumulation. In parallel experiments, adenosine and NPY dose-dependently decreased forskolin-induced cyclic AMP accumulation without affecting resting levels. Phenylephrine slightly increased forskolin (1 microM)-induced cyclic AMP accumulation, whereas treatment with agents that increase or mimic cyclic AMP (forskolin, prostaglandin E2, 8-Br-cyclic AMP) had no significant effect on phenylephrine-induced inositol phosphate accumulation. The previously described potentiation of the alpha 1-adrenoceptor-mediated contractile responses of the rodent vas deferens by adenosine and NPY is suggested to result from an enhanced alpha 1-adrenoceptor-induced accumulation of inositol triphosphate. Possible mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827073     DOI: 10.1016/0304-3940(87)90132-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Receptor recruitment: a mechanism for interactions between G protein-coupled receptors.

Authors:  U Holtbäck; H Brismar; G F DiBona; M Fu; P Greengard; A Aperia
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 2.  The role of neuropeptides in cardiovascular regulation.

Authors:  D Ganten; M Paul; R E Lang
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

3.  Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).

Authors:  M Adamsson; B Fallgren; L Edvinsson
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

4.  Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.

Authors:  R Andriantsitohaina; J C Stoclet
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

5.  Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors.

Authors:  C Pellieux; T Sauthier; A Domenighetti; D J Marsh; R D Palmiter; H R Brunner; T Pedrazzini
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

6.  Effect of neuropeptide Y on alpha 2-adrenoceptor-mediated cardiovascular responses in the pithed rat.

Authors:  E Vila; I M Macrae
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

7.  Stimulation of adenosine A1 receptors and bradykinin receptors, which act via different G proteins, synergistically raises inositol 1,4,5-trisphosphate and intracellular free calcium in DDT1 MF-2 smooth muscle cells.

Authors:  P Gerwins; B B Fredholm
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Enhancement by neuropeptide Y (NPY) of the dihydropyridine-sensitive component of the response to alpha 1-adrenoceptor stimulation in rat isolated mesenteric arterioles.

Authors:  R Andriantsitohaina; J C Stoclet
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

9.  Differences in the adenosine receptors modulating inositol phosphates and cyclic AMP accumulation in mammalian cerebral cortex.

Authors:  S P Alexander; D A Kendall; S J Hill
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

10.  Inhibition of noradrenaline release by neuropeptide Y in mouse atria does not involve inhibition of adenylate cyclase or a pertussis toxin-susceptible G protein.

Authors:  S Foucart; H Majewski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.